The United States Food and Drug Administration (USFDA) has banned over 30 generic medicines manufactured by Ranbaxy Laboratories after two of its manufacturing plants were found to have not followed the good manufacturing practices prescribed by the US authorities. The authority however clarified that there is no evidence to doubt the quality of the products that have been shipped by Ranbaxy.
The details can be read here.
No comments:
Post a Comment